RARE CANCER PATIENTS
From 2012 to 2016, 75% of clinical trials did not specifically include any rare cancers.
As of 2018, 79% of cancer patients lacking approved targeted therapy have a rare cancer.
"ALL #ChildhoodCancers are considered "rare". We can & must do better - every child deserves access to life-saving #therapies! SHARE the #RareIsntRare campaign to #advocate & let the world know that we will no longer accept death sentences for our children."
SHARE YOUR SUPPORT
Sample Tweets and Social Posts
Amplify the campaign by posting your support along with a picture of your bracelet because #RareIsntRare.
Today I’m wearing my support for the @SHEPHERDFound #RareIsntRare Campaign. Join me in demanding #equity for all #RareCancer #patients.
Did you know all #ChildhoodCancers are considered #RareCancers? They all deserve better. Join the @SHEPHERDFound #RareIsntRare campaign to change the system.
Survival shouldn't be determined by skin color, age, zip code, income, circumstance, or specific #cancer #diagnosis. Join the @SHEPHERDFound #RareIsntRare campaign to rethink #HealthJustice & elevate the voices of neglected & underserved #patient communities.
Every patient deserves the right to live - regardless of their diagnosis. Support the @SHEPHERDFound #RareIsntRare campaign to change the narrative around #RareCancers - so that no patient is left to die.
All patients deserve access to life-saving therapies, resources and funding. Join me in supporting the @SHEPHERDFound #RareIsntRare campaign to amplify the voices of the #RareCancer community.
igniting the conversation with our partner
BIRD & STONE
We are committed to ethically-made products that support organizations building a more equal world.
We believe in creating a community of changemakers, and leveraging our collective purchasing power to drive change.